710 related articles for article (PubMed ID: 15285001)
41. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
Sasso EH
Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
[TBL] [Abstract][Full Text] [Related]
42. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Sebastiani M; Fallahi P
J Rheumatol; 2010 Jan; 37(1):91-7. PubMed ID: 19918044
[TBL] [Abstract][Full Text] [Related]
43. [Extrahepatic manifestations of chronic hepatitis C].
Ignatova TM; Aprosina ZG; Serov VV; Mukhin NA; Krel' PE; Semenkova EN; Popova IV; Tanashchuk EL
Ter Arkh; 1998; 70(11):9-16. PubMed ID: 9949448
[TBL] [Abstract][Full Text] [Related]
44. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients.
Antonelli A; Ferri C; Fallahi P; Sebastiani M; Nesti C; Barani L; Barale R; Ferrannini E
Rheumatology (Oxford); 2004 Feb; 43(2):238-40. PubMed ID: 13130149
[TBL] [Abstract][Full Text] [Related]
45. Mixed cryoglobulinemia.
Ferri C
Orphanet J Rare Dis; 2008 Sep; 3():25. PubMed ID: 18796155
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis C virus, mixed cryoglobulinaemia and non-Hodgkin's lymphoma.
Mazzaro C; Efremov DG; Burrone O; Pozzato G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):428-34. PubMed ID: 9789144
[TBL] [Abstract][Full Text] [Related]
47. [Chronic hepatitis C virus infection].
Iñarrairaegui M; Elizalde I; Martínez Echeverría A; Zozaya JM; Beloqui R; Martínez Peñuela JM
An Sist Sanit Navar; 2004; 27 Suppl 2():69-80. PubMed ID: 15381945
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.
Shirin H; Davidovitz Y; Avni Y; Petchenko P; Krepel Z; Bruck R; Meytes D
Isr Med Assoc J; 2002 Jan; 4(1):24-7. PubMed ID: 11802304
[TBL] [Abstract][Full Text] [Related]
49. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia.
Saadoun D; Sellam J; Ghillani-Dalbin P; Crecel R; Piette JC; Cacoub P
Arch Intern Med; 2006 Oct; 166(19):2101-8. PubMed ID: 17060540
[TBL] [Abstract][Full Text] [Related]
50. Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia.
Alpa M; Ferrero B; Cavallo R; Naretto C; Menegatti E; Di Simone D; Napoli F; La Grotta R; Rossi D; Baldovino S; Sena LM; Roccatello D
Autoimmun Rev; 2008 Oct; 8(1):56-8. PubMed ID: 18703170
[TBL] [Abstract][Full Text] [Related]
51. HCV-associated lymphomas.
Fiorilli M; Mecucci C; Farci P; Casato M
Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
[TBL] [Abstract][Full Text] [Related]
52. The pathophysiology of HCV induced B-cell clonal disorders.
Landau DA; Saadoun D; Calabrese LH; Cacoub P
Autoimmun Rev; 2007 Sep; 6(8):581-7. PubMed ID: 17854753
[TBL] [Abstract][Full Text] [Related]
53. Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia.
Fabris M; Quartuccio L; Salvin S; Pozzato G; De Re V; Mazzaro C; Ferri C; Baldini C; De Vita S
Ann Rheum Dis; 2008 Jan; 67(1):80-3. PubMed ID: 17526550
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis.
Sansonno D; Gesualdo L; Manno C; Schena FP; Dammacco F
Hepatology; 1997 May; 25(5):1237-44. PubMed ID: 9141444
[TBL] [Abstract][Full Text] [Related]
55. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
Saadoun D; Bieche I; Maisonobe T; Asselah T; Laurendeau I; Piette JC; Vidaud M; Cacoub P
Arthritis Rheum; 2005 Sep; 52(9):2917-25. PubMed ID: 16142759
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer.
Ramos-Casals M; De Vita S; Tzioufas AG
Autoimmun Rev; 2005 Jan; 4(1):8-15. PubMed ID: 15652773
[TBL] [Abstract][Full Text] [Related]
57. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
58. Mixed cryoglobulinemia: new concepts.
Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; Font J
Lupus; 2000; 9(2):83-91. PubMed ID: 10787003
[TBL] [Abstract][Full Text] [Related]
59. HCV infection: pathogenesis, clinical manifestations and therapy.
Antonelli A; Ferri C; Galeazzi M; Giannitti C; Manno D; Mieli-Vergani G; Menegatti E; Olivieri I; Puoti M; Palazzi C; Roccatello D; Vergani D; Sarzi-Puttini P; Atzeni F
Clin Exp Rheumatol; 2008; 26(1 Suppl 48):S39-47. PubMed ID: 18570753
[TBL] [Abstract][Full Text] [Related]
60. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
